Your browser doesn't support javascript.
loading
Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis.
Troullioud Lucas, Alexandre G; Lindemans, Caroline A; Bhoopalan, Senthil Velan; Dandis, Rana; Prockop, Susan E; Naik, Swati; Keerthi, Dinesh; de Koning, Coco; Sharma, Akshay; Nierkens, Stefan; Boelens, Jaap Jan.
Afiliación
  • Troullioud Lucas AG; Transplantation and Cellular Therapy, MSK Kids, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Lindemans CA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatrics, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Bhoopalan SV; Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Dandis R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Prockop SE; Pediatric Stem Cell Transplantation, Boston Children's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Naik S; Department of Bone Marrow Transplantation and Cell Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Keerthi D; Department of Bone Marrow Transplantation and Cell Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • de Koning C; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Sharma A; Department of Bone Marrow Transplantation and Cell Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Boelens JJ; Transplantation and Cellular Therapy, MSK Kids, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Electronic address: boelensj@mskcc.org.
Cytotherapy ; 25(9): 977-985, 2023 09.
Article en En | MEDLINE | ID: mdl-37330731

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Reconstitución Inmune / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Child / Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Reconstitución Inmune / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Child / Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos